Citations (4)


Footnotes (385)



Shareholder Bylaws, Shareholder Nominations, and Poison Pills

Brett McDonnell

University of Minnesota Law School

January 28, 2005

Minnesota Legal Studies Research Paper No. 05-06

Shareholder bylaws limiting or directing board action raise a tough and fascinating question of statutory interpretation under state law as well as an important policy question. In particular, over the last decade shareholders have sought to use bylaws to limit poison pills and to grant shareholders access to the corporate proxy materials to nominate directors. This paper argues that an expansive, although not unlimited, shareholder power to enact bylaws is both a plausible interpretation of Delaware's statutory scheme and desirable as a policy matter. Shareholder bylaws that set general rules of corporate governance and procedure should be valid unless more specific statutory provisions remove a specific matter from the bylaw power. Applied to poison pill and proxy access bylaws, both are valid under the general analysis, although poison pill bylaws may not be valid due to a more specific provision of Delaware law. The SEC should require boards to include bylaw proposals unless the particular proposal is clearly invalid under relevant state law. Board bylaws and certificate provisions could limit shareholder bylaws in some corporations, but it is likely that in many corporations boards will not be willing or able to enact such limits.

Number of Pages in PDF File: 101

Keywords: bylaws, proxy access, shareholder nominations, poison pills

JEL Classification: G30, K22, L23

Open PDF in Browser Download This Paper

Date posted: February 2, 2005  

Suggested Citation

McDonnell, Brett, Shareholder Bylaws, Shareholder Nominations, and Poison Pills (January 28, 2005). Minnesota Legal Studies Research Paper No. 05-06. Available at SSRN: https://ssrn.com/abstract=659322 or http://dx.doi.org/10.2139/ssrn.659322

Contact Information

Brett H. McDonnell (Contact Author)
University of Minnesota Law School ( email )
229 19th Avenue South
Minneapolis, MN 55455
United States
612-625-1373 (Phone)

Feedback to SSRN

Paper statistics
Abstract Views: 5,208
Downloads: 447
Download Rank: 49,315
Citations:  4
Footnotes:  385